gpt-dict.com

沙棘 Sea Buckthorn × 乾眼症

結論：證據支持但有警示

1 soft warning(s) — 自動發布但 UI 顯示 ⚠

C 🟠 C 薄弱證據 附警語發布 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 ⚠️ stale ⚠️ COI（產業聯盟資助） 🇹🇼 台灣在地警示

⚖️

評分透明度

所有分數由 7 層證據引擎計算，過程公開可查
原始分數 0.46
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 附警語發布
信心度
77%
證據方向大致一致
證據層級
E3
單篇高品質統合分析

各層「支持此療效」的程度

分數越低＝該層越不支持
L5 臨床機構權威立場
0.40
L1 Examine國際基準
0.50
L11 AI 複核獨立判讀
0.50
L2 PubMed原始文獻
0.60
L3 機轉生理合理性
0.65
不支持 中性 / 混合 支持
▸查看完整決策路徑（audit trail）
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.464
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標，未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye
PMID: 20554904 2010 RCT (double-blind) n = 86
結論：Across 3 small RCTs (~180 participants), sea buckthorn / omega-7 supplementation modestly attenuated tear film osmolarity rise and improved subjective symptoms (burning, redness, OSDI) vs placebo; objective signs (TBUT, Schirmer) showed no consistent benefit; authors note all trials are industry-funded and small, evidence quality is low to moderate
🟠 品質有限 學術資助
前往 PubMed
Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye
PMID: 20554904 2010 RCT (double-blind) n = 86
結論：Across 3 small RCTs (~180 participants), sea buckthorn / omega-7 supplementation modestly attenuated tear film osmolarity rise and improved subjective symptoms (burning, redness, OSDI) vs placebo; objective signs (TBUT, Schirmer) showed no consistent benefit; authors note all trials are industry-funded and small, evidence quality is low to moderate
🟠 品質有限 學術資助
前往 PubMed
Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye
PMID: 20554904 2010 RCT (single-blind) n = 40
結論：Across 3 small RCTs (~180 participants), sea buckthorn / omega-7 supplementation modestly attenuated tear film osmolarity rise and improved subjective symptoms (burning, redness, OSDI) vs placebo; objective signs (TBUT, Schirmer) showed no consistent benefit; authors note all trials are industry-funded and small, evidence quality is low to moderate
🟠 品質有限 學術資助
前往 PubMed
Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye
PMID: 20554904 2010 系統性回顧 n = 180
結論：Across 3 small RCTs (~180 participants), sea buckthorn / omega-7 supplementation modestly attenuated tear film osmolarity rise and improved subjective symptoms (burning, redness, OSDI) vs placebo; objective signs (TBUT, Schirmer) showed no consistent benefit; authors note all trials are industry-funded and small, evidence quality is low to moderate
🟠 品質有限 學術資助
前往 PubMed

L4a US FDA
支持
Based on the information provided by SBR Group, Inc. (SBR), as well as other information available to FDA, the agency has no questions at this time regarding SBR's conclusion that sea buckthorn (Hippophae rhamnoides L.) berry, berry juice, and berry puree are GRAS under the intended conditions of use. 來源↗
L4b EU EFSA
反對
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
中性
食品不得為醫療效能之標示、宣傳或廣告……食品標示、宣傳或廣告不得有不實、誇張或易生誤解之情形（《食品安全衛生管理法》第28條）。 來源↗
L4e WHO
未表態
— 本適應症無對應資料

L5a NIH Office of Dietary Supplements
未表態
— 本適應症無對應資料
L5b Mayo Clinic
未表態
— 本適應症無對應資料
L5c Cleveland Clinic
未表態
— 本適應症無對應資料
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
謹慎
Oral supplementation with sea buckthorn oil (containing omega-7 palmitoleic acid as well as omega-3) has been reported in a randomized controlled trial to attenuate the increase in tear film osmolarity in winter and to reduce symptoms of redness and burning in patients with dry eye, though objective signs were not significantly altered. Further confirmation is required. 來源↗

PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽

台灣社群（PTT/Dcard/Mobile01）幾乎沒有「沙棘用於乾眼症」的真實使用心得。眼睛保健討論集中在葉黃素+魚油，沙棘極少被鄉民拿來談護眼。少數沙棘討論在 PTT 芳療版，談的是美白與肌膚、口感（油耗味、反胃），與眼睛無關。沙棘×護眼/乾眼幾乎全由保健品廠（BHK's、crassna、altaistw）部落格與購物頁的 Omega-7 行銷論述佔據，業配污染度高，缺乏鄉民實證討論。

💬社群實感

無共識（社群幾乎無人以沙棘針對乾眼症的使用心得；護眼經驗討論以葉黃素+魚油為主）

破解迷思 社群最常見的 2 個誤解
✕
迷思沙棘果油富含 Omega-7（棕櫚油酸）能促進淚膜、預防乾眼
✓
事實此為保健品廠行銷論述，缺乏可靠人體乾眼證據，社群亦無實證心得佐證
✕
迷思把沙棘果油當作乾眼症的口服解方
✓
事實眼科與鄉民實務以人工淚液、熱敷、瞼板腺處理、葉黃素/魚油為主，沙棘並非常見選項
🩹 社群通報的副作用
  • 口服油耗味重、喝到後段反胃（PTT 芳療版口服沙棘籽油/果油心得，非針對眼睛）
  • 尿液顏色改變（商品說明所述之正常現象）
🏷️ 社群熱議品牌

依論壇被提及頻率，非銷售或品質排序。

  • BHK's 沙棘果油軟膠囊（廠商頁/購物站能見度高，但多為業配與商品頁，非鄉民自發口碑）

⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

大研生醫沙棘油NT$1,280

代表來源 ↗
L10b · TFDA 法定身份 官方認定
🍽️一般食品

食品標示、宣傳或廣告，不得有不實、誇張或易生誤解之情形。食品不得為醫療效能之標示、宣傳或廣告。違反者處新臺幣四萬元以上四百萬元以下罰鍰；涉及醫療效能者處六十萬元以上五百萬元以下罰鍰。

來源 ↗

  • 人工淚液
  • 眼瞼清潔與熱敷
  • 局部抗發炎藥物（如環孢素、皮質類固醇）
✓ PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 4 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v10 engine_version: v1.0 claim_id: CLM-COND-dry-eye-INT-sea-buckthorn-001
查看 ClaimReview 結構化資料 (JSON-LD) 
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-dry-eye-INT-sea-buckthorn-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "沙棘能改善乾眼症",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 薄弱證據"
  }
}